Company : GlycoMar Limited

Category : Biotechnology

Drug discovery screening

GlycoMar specialist screening facility has been established to provide flexible in vitro screening services to a wide range of organisations involved in therapeutic discovery. GlycoMar offers a suite of cost effective primary screens, using cells from healthy human donor volunteers and cell lines:


Marker

Cell type

Inflammatory Cytokine profiling

Human whole blood, PBMCs, or Neutrophils, keratinocytes, or endothelial cells

Elastase release

Human Neutrophils

Chemotaxis

Human Neutrophils

Transendothelial migration

Human Neutrophils, human umbilical vein endothelial cells (HUVECs)

Oxidative burst

Human Neutrophils and lymphocytes

Activated Partial Thromboplastin Time (APTT)

Fresh human plasma sheep plasma

Cytotoxicity

BHK & HeLa cells

Other Products

Drug discovery

Nutraceutical discovery

Glycobiology analytical services